about
Mesoblast Ltd is a commercial-stage biotechnology company and a world leader in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions. The company's product candidates includ...
Read More
17.27
-0.59
(-3.30%)
317.0K
XNAS Volume
XNAS 17 Jul, 2026 3:04 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Mesoblast Ltd (ADR) Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..